Related Experiment Video
Updated: May 6, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Roles of cardiovascular risk factors in endothelial nitric oxide synthase regulation: an update
Md Saha Jamaluddin, Zhengdong Liang, Jian-Ming Lu
1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, Texas 77030, USA. jchen@bcm.tmc.edu.
Insights
Cardiovascular risk factors impair the endothelial nitric oxide synthase-nitric oxide (eNOS-NO) system. Understanding these mechanisms is key to developing new strategies for preventing and treating cardiovascular disease.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Vascular Biology
Background:
- Cardiovascular disease is a leading cause of death globally.
- Research focuses on understanding cardiovascular risk factors and their impact on the vascular system.
- The endothelial nitric oxide synthase-nitric oxide (eNOS-NO) system plays a crucial role in vascular health.
Purpose of the Study:
- To review current research on how cardiovascular risk factors affect the eNOS-NO system.
- To highlight discoveries related to both established and emerging risk factors.
- To explore the molecular mechanisms underlying eNOS-NO system impairment.
Main Methods:
- Literature review of recent studies on cardiovascular risk factors and the eNOS-NO system.
- Analysis of molecular mechanisms by which risk factors impact eNOS expression, activity, and NO bioavailability.
- Focus on established risks (hypertension, smoking, dyslipidemia, diabetes) and emerging risks (HIV, antiretroviral therapy, genetics, cytokines).
Main Results:
- Cardiovascular risk factors commonly impair the eNOS-NO system.
- Mechanisms include reduced NO bioavailability due to reactive oxygen species, inhibited eNOS expression/activity, and cofactor deficiency.
- Emerging risk factors like HIV infection and antiretroviral therapy also impact the eNOS-NO system.
Conclusions:
- Cardiovascular risk factors disrupt the eNOS-NO system through various molecular pathways.
- Understanding these disruptions is vital for developing novel prevention and treatment strategies.
- Further research into emerging risk factors' effects on the eNOS-NO system is warranted.
Abstract:
Cardiovascular disease remains the number one killer in the United States and many other countries. Each year, there are enormous research efforts on its pathogenesis, prevention and treatment led by scientists worldwide. One of the most significant research areas is the impact and mechanisms of existing or new cardiovascular risk factors on the vascular system. The current review provides the most updated research advances in the area of the regulation of the endothelial nitric oxide synthase-nitric oxide (eNOS-NO) system by several cardiovascular risk factors. There are many exciting discoveries made from the studies of several major cardiovascular risk factors such as hypertension, cigarette smoking, dyslipidemia and diabetes mellitus as well as emerging risk factors such as HIV infection, antiretroviral therapy, genomic variability, and cytokines. In general, cardiovascular risk factors could impair the eNOS-NO system with a variety of molecular mechanisms including decrease in NO bioavailability by excess reactive oxygen species, inhibition of eNOS expression and activity, and deficiency of eNOS cofactors. Special attention is paid to the impact of several new or emerging risk factors on cardiovascular disease and the eNOS-NO system. These mechanistic studies are clinically significant because they may lead towards new and effective strategies for the prevention and treatment of cardiovascular disease.
Related Concept Videos
Nitric Oxide Signaling Pathway
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

